Patents by Inventor Wai-Tak Law

Wai-Tak Law has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100047848
    Abstract: A simple calorimetric in-line quantitative test to measure white blood cell counts in milk samples using a liquid reagent system that simplifies quantitative in-line SCC measurements using a reflectance measuring mode, and a new apparatus, which permits in-line colorimetric analysis.
    Type: Application
    Filed: October 26, 2009
    Publication date: February 25, 2010
    Inventors: Wai Tak Law, Robert Douglas Harper
  • Publication number: 20080057596
    Abstract: The invention involves using a simple colorimetric method for a quantitative test to measure white blood cells in milk samples. The invention includes a new reagent system, a new analysis method, and a new apparatus which permits in-line colorimetric analysis.
    Type: Application
    Filed: August 30, 2006
    Publication date: March 6, 2008
    Inventors: Wai Tak Law, Robert Douglas Harper
  • Patent number: 6759009
    Abstract: A self-contained analyzer quantitatively detects a clotting event in a biological fluid. The device includes a base having an open reservoir for receiving the biological fluid. A carrier for a dried activator reagent is located in or adjacent to the open reservoir. The biological fluid reconstitutes the dried reagent and starts the clotting process. During the clotting process the fluid travels through a capillary flow channel lined with a precision woven fabric. When clotting is completed, the woven fabric stops the flow of the fluid. A colored bar formed by the fluid flowing through the capillary channel indicates the length of time required for clotting of the sample.
    Type: Grant
    Filed: May 6, 2002
    Date of Patent: July 6, 2004
    Assignee: Portascience Incorporated
    Inventor: Wai Tak Law
  • Patent number: 6709868
    Abstract: A method for quantitatively measuring white blood cell count involves capture of white blood cells from a fluid sample by a retainer, removal of the red blood cells and other interfering substances by a wash solution, and reading the result of a color reaction in which an ester which is present on the white blood cells cleaves a chromogenic substrate which produces a water insoluble dye. The apparatus for use in the present method includes a retainer for white blood cells that has a dye substrate immobilized therein and an absorption layer that wicks and takes up all excess washing solution flowing past the sample.
    Type: Grant
    Filed: May 20, 2002
    Date of Patent: March 23, 2004
    Assignee: Portascience Inc.
    Inventors: Wai Tak Law, Yuri Nikolyukin, Inna Nikolyukin
  • Publication number: 20030215951
    Abstract: A method for quantitatively measuring white blood cell count involves capture of white blood cells from a fluid sample by a retainer, removal of the red blood cells and other interfering substances by a wash solution, and reading the result of a color reaction in which an ester which is present on the white blood cells cleaves a chromogenic substrate which produces a water insoluble dye. The apparatus for use in the present method includes a retainer for white blood cells that optionally has a dye substrate immobilized therein and an absorption layer that wicks and takes up all excess washing solution flowing past the sample.
    Type: Application
    Filed: May 20, 2002
    Publication date: November 20, 2003
    Inventors: Wai Tak Law, Yuri Nikolyukin, Inna Nikolyukin
  • Patent number: 6562581
    Abstract: A method and a system for separating glycated hemoglobin from non-glycated hemoglobin, and a method for one-read quantitative determination of the glycated hemoglobin and % HbA1c that does not require an additional measurement of total hemoglobin.
    Type: Grant
    Filed: August 31, 2001
    Date of Patent: May 13, 2003
    Assignee: Portascience
    Inventors: Wai Tak Law, Yuri Nikolyukin
  • Publication number: 20030073243
    Abstract: A method and a system for separating glycated hemoglobin from non-glycated hemoglobin, and a method for one-read quantitative determination of the glycated hemoglobin and %HbA1c that does not require an additional measurement of total hemoglobin.
    Type: Application
    Filed: August 31, 2001
    Publication date: April 17, 2003
    Inventors: Wai Tak Law, Yuri Nikolyukin
  • Publication number: 20020187071
    Abstract: A self-contained analyzer quantitatively detects a clotting event in a biological fluid. The device includes a base having an open reservoir for receiving the biological fluid. A carrier for a dried activator reagent is located in or adjacent to the open reservoir. The biological fluid reconstitutes the dried reagent and starts the clotting process. During the clotting process the fluid travels through a capillary flow channel lined with a precision woven fabric. When clotting is completed, the woven fabric stops the flow of the fluid. A colored bar formed by the fluid flowing through the capillary channel indicates the length of time required for clotting of the sample.
    Type: Application
    Filed: May 6, 2002
    Publication date: December 12, 2002
    Applicant: PORTASCIENCE INCORPORATED
    Inventor: Wai Tak Law
  • Patent number: 5914271
    Abstract: The fertile period in a female can be detected by monitoring the calcium and magnesium concentrations in unstimulated saliva. In the three to five day period immediately prior to ovulation, the calcium and magnesium concentrations of saliva drop. This concentration monitoring can be done by any conventional means for quantitatively assaying calcium or magnesium, such as by flow through tests, test strips, cards, charts, probes, meters, and the like.
    Type: Grant
    Filed: April 17, 1997
    Date of Patent: June 22, 1999
    Assignee: ActiMed Laboratories, Inc.
    Inventors: Wai Tak Law, Robert Harper
  • Patent number: 5766552
    Abstract: Red blood cells are removed from whole blood or a fraction thereof by agglutinating whole blood with a mixture of a free agglutinating agent and nucleating particles having agglutinating agent intimately associated therewith to form clusters of red blood cells. High molecular weight polyethylene glycol may be added further to enhance agglutination. The clusters of red blood cells are much larger than the size of individual red blood cells, so that the clusters can easily be filtered through a porous medium. The plasma, which is substantially free of red blood cells, is further passed through a filter that optionally contains an additional agglutinating agent. Flow-delay additives may be provided to retain the fluid sample in contact with a reagent for a predetermined time.
    Type: Grant
    Filed: February 5, 1996
    Date of Patent: June 16, 1998
    Assignee: ActiMed Laboratories, Inc.
    Inventors: Sonal R. Doshi, John K. McGeehan, Wai Tak Law
  • Patent number: 5660798
    Abstract: Red blood cells are removed from whole blood or a fraction thereof by contacting whole blood with a combination of an agglutinating agent and nucleating particles to form clusters of red blood cells. High molecular weight polyethylene glycol may be added further to enhance agglutination. The clusters of red blood cells are much larger than the size of individual red blood cells, so that the clusters can easily be filtered through a porous medium. The plasma which is substantially free of red blood cells is further passed through a filter that optionally contains an additional agglutinating agent. Flow-delay means may be provided to return the fluid sample in contact with a regard for a predetermined time.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 26, 1997
    Assignee: ActiMed Laboratories, Inc.
    Inventors: Sonal R. Doshi, John K. McGeehan, Wai Tak Law
  • Patent number: 5652148
    Abstract: Red blood cells are removed from whole blood or a fraction thereof by contacting whole blood with a combination of an agglutinating agent and nucleating particles to form clusters of red blood cells. High molecular weight polyethylene glycol may be added further to enhance agglutination. The clusters of red blood cells are much larger than the size of individual red blood cells, so that the clusters can easily be filtered through a porous medium. The plasma which is substantially free of red blood cells is further passed through a filter that optionally contains an additional agglutinating agent.
    Type: Grant
    Filed: April 20, 1993
    Date of Patent: July 29, 1997
    Assignee: Actimed Laboratories, Inc.
    Inventors: Sonal R. Doshi, John K. McGeehan, Wai Tak Law
  • Patent number: 4278440
    Abstract: A direct, quantitative method is provided for the determination of chloride in blood serum which is based on the reaction between the chloride and ferric ions. A novel reagent is employed in the method which contains no mercury but does contain a surfactant which prevents protein precipitation.
    Type: Grant
    Filed: February 4, 1980
    Date of Patent: July 14, 1981
    Assignee: Union Carbide Corporation
    Inventors: Wai-Tak Law, Gerhard Ertingshausen